Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 1, 2008, Pages 79-87

  Ricci, Alberto ^a   Mariotta, Salvatore ^a   Amenta, Francesco ^b   Tayebati, Seyed Khosrow ^b   Terzano, Claudio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Human; Immunoblot; Immunocytochemistry; lymphocytes; Muscarinic receptor subtypes

Indexed keywords

METHACHOLINE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; RADIOLIGAND; RECEPTOR PROTEIN; RECEPTOR SUBTYPE;

ADULT; ALLERGIC RHINITIS; ARTICLE; BINDING ASSAY; BRONCHUS HYPERREACTIVITY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RECEPTOR UPREGULATION;

ADULT; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; LYMPHOCYTES; MALE; RADIOLIGAND ASSAY; RECEPTORS, MUSCARINIC; RHINITIS, ALLERGIC, PERENNIAL; SEVERITY OF ILLNESS INDEX;

EID: 38049039163     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2006.12.006     Document Type: Article

References (49)

1. Barnes P.J. Neural control of human airways in health and diseases. Am Rev Respir Dis 134 (1986) 1289-1314
2. Richardson J.B. Nerve supply to the lungs. Am Rev Respir Dis 119 (1979) 785-802
3. Okayama M., Mullol J., Baraniuk J.N., Hausfeld J.N., Feldman B., Merida M., et al. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro. Am J Respir Cell Mol Biol 8 (1993) 176-187
4. Barnes P.J. Distribution of receptor targets in the lung. Proc Am Thorac Soc 1 (2004) 345-351
5. Caulfield M.P., and Birdsall N.J. International Union of Pharmacology, XVII: classification of muscarinic acetylcholine receptors. Pharmacol Rev 50 (1998) 279-290
6. Caulfield M.P., Robbins J., Higashida H., and Brown D.A. Postsynaptic actions of acetylcholine: the coupling of muscarinic receptor subtypes to neuronal ion channels. Prog Brain Res 98 (1993) 293-301
7. Felder C.C. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 9 (1995) 619-625
8. Gross N.J. Ipratropium bromide. N Engl J Med 319 (1988) 486-494
9. Baroody F.M., Wagenmann M., and Naclerio R.M. Comparison of the secretory response of the nasal mucosa to methacholine and histamine. J Appl Physiol 74 (1993) 2661-2671
10. Barnes P.J. Cholinergic control of airway smooth muscle. Am Rev Respir Dis 136 (1987) S42-S45
11. Minette P.A., and Barnes P.J. Muscarinic receptor subtypes in lung: clinical implications. Am Rev Respir Dis 141 (1990) S162-S165
12. Baraniuk J.N., Silver P.B., Kaliner M.A., and Barnes P.J. Effects of ipratropium bromide on bradykinin nasal provocation in chronic allergic rhinitis. Clin Exp Allergy 24 (1994) 724-729
13. Meltzer E.O., Orgel H.A., Bronsky E.A., Findlay S.R., Georgitis J.W., Grossman J., et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol 90 (1992) 242-249
14. Bronsky E.A., Druce H., Findlay S.R., Hampel F.C., Kaiser H., Ratner P., et al. Clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol 95 (1995) 1117-1122
15. Witek Jr. T.J. The fate of inhaled drugs: the pharmacokinetics and pharmacodynamics of drugs administered by aerosol. Respir Care 45 (2000) 826-830
16. Salib R.J., Drake-Lee A., and Howarth P.H. Allergic rhinitis: past, present and the future. Clin Otolaryngol 28 (2003) 291-303
17. Borish L. Allergic rhinitis: systemic inflammation and implications for management. J Allergy Clin Immunol 112 (2003) 1021-1031
18. Maslinski W. Cholinergic receptors of lymphocytes. Brain Behav Immunol 3 (1989) 1-14
19. Ader R., Felten D., and Cohen N. Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol 30 (1990) 561-602
20. Rinner I., and Schauenstein K. Detection of choline-acetyltransferase activity in lymphocytes. J Neurosci Res 35 (1993) 188-191
21. Tayebati S.K., Codini M., Gallai V., Mannino F., Parnetti L., Ricci A., et al. Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol 99 (1999) 224-229
22. Bany U., Ryzewski J., and Maslinski W. Relative amounts of mRNA encoding four subtypes of muscarinic receptors (m2-m5) in human peripheral blood mononuclear cells. J Neuroimmunol 97 (1999) 191-195
23. 3H-N-metyl-scopolamine binding in neurological patients. Brain 144 (1991) 1759-1770
24. Rabey J.M., Grynberg E., and Graff E. Cholinergic muscarinic binding of blood lymphocytes in patients with Parkinson's disease. Adv Neurol 53 (1990) 129-134
25. Anlar B., Karaszewski J.W., Reder A.T., and Arnason B.G. Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis. J Neuroimmunol 36 (1992) 171-177
26. 3H]-QNB binding to lymphocytes in Gilles de la Tourette syndrome. Biol Psychiatry 31 (1992) 889-895
27. Laskowska-Bozek H., Filipowicz-Sosnowska A., Zubrzycka-Sienkiewicz A., and Ryzewski J. Expression of muscarinic cholinergic receptors on lymphocytes in various subsets of rheumatoid arthritis and their variabilities connected with treatment. J Rheumatol 21 (1994) 1214-1219
28. Chiba Y., and Misawa M. Characteristics of muscarinic cholinoceptors in airways of antigen-induced airway hyperresponsive rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 111 (1995) 351-357
29. Masuyama K., Uno K., Minoda R., Eura M., Samejima Y., and Ishikawa T. Muscarinic acetylcholine receptors on human lymphocytes in patient's with Meniere's disease. Acta Otolaryngol 116 (1996) 369-373
30. Haddad E.B., Mak J.C., Belvisi M.G., Nishikawa M., Rousell J., and Barnes P.J. Muscarinic and beta-adrenergic receptor expression in peripheral lung from normal and asthmatic patients. Am J Physiol 270 (1996) L947-L953
31. Zaagsma J., Roffel A.F., and Meurs H. Muscarinic control of airway function. Life Sci 60 (1997) 1061-1068
32. Ricci A., Mannino F., Bronzetti E., Felici L., Adani O., Gemma D., et al. Peripheral blood lymphocyte muscarinic cholinergic receptors in airway hyperresponsiveness: a marker of cholinergic dysfunction?. J Autonom Pharmacol 18 (1998) 251-255
33. Ricci A., Amenta F., Bronzetti E., Mannino F., Mariotta S., and Tayebati S.K. Expression of peripheral blood lymphocyte muscarinic cholinergic receptor subtypes in airway hyperresponsiveness. J Neuroimmunol 129 (2002) 178-185
34. Guidelines for Methacholine and Exercise Challenge Testing-1999. Am J Respir Crit Care Med 161 (2000) 309-329
35. Ricci A., Bronzetti E., Conterno A., Greco S., Mulatero P., Schena M., et al. Alpha 1-adrenergic receptor subtypes in human peripheral blood lymphocytes. Hypertension 33 (1999) 708-712
36. Tayebati S.K., Amenta F., Amici S., El-Assouad D., Gallai V., Ricci A., et al. Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction?. J Neuroimmunol 121 (2001) 126-131
37. McPherson G.A. RADLIG (version 4) (1994), Cambridge, Biosoft
38. Mak J.C., and Barnes P.J. Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am Rev Respir Dis 141 (1990) 1559-1568
39. Mak J.C., Baraniuk J.N., and Barnes P.J. Localization of muscarinic receptor subtype mRNAs in human lung. Am J Respir Cell Mol Biol 7 (1992) 344-348
40. Makker H.K., and Holgate S.T. The contribution of neurogenic reflexes to hypertonic saline-induced bronchoconstriction in asthma. J Allergy Clin Immunol 92 (1993) 82-88
41. Grossman J. One airway, one disease. Chest 1997;111:11S-16S.
42. Haddad el.-B., and Rousell J. Regulation of the expression and function of the M2 muscarinic receptor. Trends Pharmacol Sci 19 (1998) 322-327
43. Jacoby D.B., and Fryer A.D. Anticholinergic therapy for airway diseases. Life Sci 68 (2001) 2565-2572
44. Lee A.M., Jacoby D.B., and Fryer A.D. Selective muscarinic receptor antagonists for airway diseases. Curr Opin Pharmacol 1 (2001) 223-229
45. Coulson F.R., and Fryer A.D. Muscarinic acetylcholine receptors and airway diseases. Pharmacol Ther 98 (2003) 59-69
46. Vinuya R.Z. Upper airway disorders and asthma: a syndrome of airway inflammation. Ann Allergy Asthma Immunol 88 (2002) 8-15
47. Belmonte K.E. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 297-304
48. Fryer A.D., and Jacoby D.B. Effect of inflammatory cell mediators on M2 muscarinic receptors in the lungs. Life Sci 52 (1993) 529-536
49. Tohda Y., Haraguchi R., Itoh M., Ohkawa K., Kubo H., Fukuoka M., et al. Role of muscarinic acetylcholine receptors in a guinea pig model of asthma. Int Immunopharmacol 2 (2002) 1521-1527